| [February 14, 2012] |
 |
Research and Markets: Global HIV Drugs Market 2010-2014 Report - The Global HIV Drugs Market to Reach US$15.5 Billion By 2014
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/1f6344/global_hiv_drugs_m)
has announced the addition of the "Global
HIV Drugs Market 2010-2014" report to their offering.
One of the key factors contributing to this market growth is the
increase in the use of highly active antiretroviral therapy. The Global
HIV Drugs market has also been witnessing the need for novel HIV drugs.
However, the expiration of patents of key drugs in 2010 could be a
challenge to the growth of this market.
Key vendors dominating this market include Gliead Sciences Inc.,
Bristol-Myers Squibb Co., Abbott Laboratories, ViiV Healthcare.
Commenting on the report, an analyst from TechNavio's Healthcare team
said, Major issues such as resistance to ART, patent expirations, and
increasing HIV infections have created a need for novel drugs. The trend
is moving towards development of new ART drugs that operate outside
infected cells. This could include new class of drugs for entry
inhibitors, coreceptor antagonists and fusion inhibitors.
According to the report, early initiation of Highly Active
AntiRetroviral Therapy (HAART) is the most effective way to reduce the
risk of blood-borne infections. New studies from British Columbia Centre
for Excellence (BC-CfE) in HIV/AIDS, San Francisco, states that HAART
was associated with a 50 percent decrease in new yearly HIV infections
among injection drug users. This driver is expected to have a huge
impact on the market.
Key findings from the report:
-
Increase in Prevalence of HIV Worldwide and Longer Life Expectancy of
Patients
-
Lack of Complete Cure and Length of Therapy
-
Development of Immune-based therapies for HIV
The contents of this report are based on research conducted on an
objective combination of primary and secondary scores, including inputs
from key participants in the industry. The report contains a
comprehensive market and vendor landscape in addition to a swot analysis
of the key players.
For more information visit http://www.researchandmarkets.com/research/1f6344/global_hiv_drugs_m
[ Back To TMCnet.com's Homepage ]
|
TMCnet LOGIN
Webinars
